Laurus Labs Ltd
NSE:LAURUSLABS

Watchlist Manager
Laurus Labs Ltd Logo
Laurus Labs Ltd
NSE:LAURUSLABS
Watchlist
Price: 566.1 INR 1.23% Market Closed
Market Cap: 305.2B INR
Have any thoughts about
Laurus Labs Ltd?
Write Note

Laurus Labs Ltd
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Laurus Labs Ltd
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Laurus Labs Ltd
NSE:LAURUSLABS
Total Other Income
â‚ą224.6m
CAGR 3-Years
6%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Other Income
â‚ą9.1B
CAGR 3-Years
25%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Other Income
â‚ą7.8B
CAGR 3-Years
42%
CAGR 5-Years
17%
CAGR 10-Years
15%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Other Income
â‚ą15.8B
CAGR 3-Years
25%
CAGR 5-Years
12%
CAGR 10-Years
12%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Other Income
â‚ą942.9m
CAGR 3-Years
-12%
CAGR 5-Years
5%
CAGR 10-Years
-4%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Other Income
â‚ą768.7m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Laurus Labs Ltd
Glance View

Market Cap
305.1B INR
Industry
Pharmaceuticals

Laurus Labs Ltd., an Indian pharmaceutical powerhouse, has etched its presence in the global pharma industry with a focus on delivering affordable and high-quality active pharmaceutical ingredients (APIs). Founded in 2005, the company's trajectory has been nothing short of remarkable, with an emphasis on research-driven production and sustainability. The Hyderabad-based conglomerate cultivates its core expertise within key therapeutic areas such as antiviral, cardiovascular, and oncology medications. By amalgamating scientific prowess with cutting-edge manufacturing facilities, Laurus Labs has positioned itself as a fundamental supplier in the fight against global ailments, providing APIs to some of the most critical generic pharmaceuticals worldwide. The company's commitment to health innovation is reflected in its robust portfolio of over 60 commercialized APIs, substantiating its pivotal role in the pharmaceutical supply chain. Adding another feather to its cap, Laurus Labs has ventured into the formulation business, manufacturing finished dosage forms that reach consumers directly. This vertical integration allows Laurus to capture a larger share of the pharmaceutical value chain, maximizing returns from its research and manufacturing capabilities. The company's foray into generic formulations has opened doors to new markets, particularly in challenging economies where cost-effective treatment is crucial. By leveraging its API expertise to produce effective, high-quality generic medications, Laurus Labs not only enhances its profitability but also adheres to its founding ethos of making healthcare accessible. With investments in research and development and a commitment to expanding its product line, Laurus Labs continues to strengthen its presence while nurturing partnerships globally, fueling its growth trajectory.

LAURUSLABS Intrinsic Value
393.12 INR
Overvaluation 31%
Intrinsic Value
Price

See Also

What is Laurus Labs Ltd's Total Other Income?
Total Other Income
224.6m INR

Based on the financial report for Sep 30, 2024, Laurus Labs Ltd's Total Other Income amounts to 224.6m INR.

What is Laurus Labs Ltd's Total Other Income growth rate?
Total Other Income CAGR 5Y
20%

Over the last year, the Total Other Income growth was 467%. The average annual Total Other Income growth rates for Laurus Labs Ltd have been 6% over the past three years , 20% over the past five years .

Back to Top